Истраживачи
Pešić, Milica
Results 21-40 of 335
| Issue Date | Title | Author(s) | Type | Мp-cat. |
|---|---|---|---|---|
| 2025 | Engineered 3D in vitro model based on Ba-alginate microfibers for rapid anticancer drug screening![]() | Petrović, Jelena | Conference Paper | Mp. category will be shown later |
| 2025 | Towards a 3D cell culture platform for anticancer drug testing![]() | Obradović, Bojana | Conference Paper | Mp. category will be shown later |
| 2025 | PARP inhibition increases sensitivity to cisplatin in non-small-cell lung carcinoma via the induction of TET-dependent hydroxymethylation | Grdović, Nevena | Article | 21aM21a |
| 2025 | Two novel pyrimidine-artesunate hybrids overcome multidrug-resistance in non-small cell lung carcinoma through collateral sensitivity | Pajović, Milica | Conference Paper | Mp. category will be shown later |
| 2025 | The impact of a protein phosphatase 2A inhibitor on glioblastoma and neurodegeneration | Chigriai, Margarita; Pešić, Vesna | Conference Paper | Mp. category will be shown later |
| 2025 | Personalized Genomic Analysis for Clinical Insights in Non-Small Cell Lung Cancer | Dragoj, Miodrag | Conference Paper | Mp. category will be shown later |
| 2025 | Development of a Clinically Relevant Temozolomide-Resistant Human Glioblastoma A-172 Cell Line | Pajović, Milica | Conference Paper | Mp. category will be shown later |
| 2025 | A simple alginate-based 3D in vitro model for preclinical anticancer drug evaluation![]() | Petrović, Jelena | Conference Paper | Mp. category will be shown later |
| 2025 | Sclareol-based natural nanoparticles with adamantane moieties exert anticancer effects against non-small cell lung carcinoma cells![]() | Stojković, Pavle | Article | 21aM21a |
| 2024 | Plant-Based Products Originating from Serbia That Affect P-glycoprotein Activity![]() | Dinić, Jelena | Article | 21M21 |
| 2024 | Novel hybrid compounds of sclareol and doxorubicin as potential anticancer nanotherapy for glioblastoma![]() | Stepanović, Ana | Article | 21a+M21a+ |
| 2024 | Hybrid Compounds of Sclareol and Doxorubicin, their Synthesis and Application | Pešić, Milica | Patent | Mp. category will be shown later |
| 2024 | Coumarins-lipophilic cations conjugates: Efficient mitocans targeting carbonic anhydrases | Fuentes-Aguilar, Alma; González-Bakker, Aday; Jovanović, Mirna | Article | 21aM21a |
| 2024 | New insight into the role of SMAD4 mutation/deficiency in the prognosis and therapeutic resistance of pancreatic ductal adenocarcinomas | Yao, Hongjuan; Luo, Liaoxin; Li, Rui; Zhao, Yelin; Zhang, Li; Pešić, Milica | Article | 21a+M21a+ |
| 2024 | Synthesis of Artesunate-Pyrimidine Hybrids and Evaluation of Their Activity Against Multidrug-Resistant Cancer Cells | Koračak, Ljiljana; Selaković, Milica | Conference Paper | Mp. category will be shown later |
| 2024 | Optimizing Treatment Response in Lung Squamous Cell Carcinoma by Cell-Based Functional Sensitivity Screening | Podolski-Renić, Ana | Article | Mp. category will be shown later |
| 2024 | Multidrug-Resistant Profiles in Non-Small Cell Lung Carcinoma Patient-Derived Cells: Implications for Personalized Approaches with Tyrosine Kinase Inhibitors | Dinić, Jelena | Article | 21M21 |
| 2024 | Towards optimized 3D cancer cell cultures in alginate-based microfiber![]() | Petrović, Jelena | Conference Paper | Mp. category will be shown later |
| 2024 | Editorial: Natural products and nanoparticles in cancer treatment: is there a light at the end of the tunnel?![]() | Pesic, Milica | Contribution to periodical | 21aM21a |
| 2024 | Development of a Biomimetic Platform for 3D Cancer Cell Cultures![]() | Obradović, Bojana | Conference Paper | Mp. category will be shown later |
